Results 161 to 170 of about 674 (175)

Pharmacological properties of a wide array of ergolines at functional alpha1-adrenoceptor subtypes

Naunyn-Schmiedeberg's Archives of Pharmacology, 2007
Klaus Peter Latte, Miroslav Flieger, Heinz H Pertz   +2 more
exaly  

THE DOPAMINEPHILLIC PROPERTIES OF ERGOLINE DERIVATIVES

1979
MENEK GOLDSTEIN, J.Y. LEW, J. ENGEL, S. NAKAMURA, A. BATTISTA   +4 more
openaire   +1 more source

Synthesis of 5(10Æ9)abeo-Ergolines

HETEROCYCLES, 1997
Sergio Mantegani, Emanuele Arlandini, Daniela Borghi, Enzo Brambilla, Mario Varasi   +4 more
openaire   +1 more source

Biosynthesis of ergot alkaloids. Evidence for two isomerizations in the isoprenoid moiety during the formation of tetracyclic ergolines

Journal of the American Chemical Society, 1968
H G Floss
exaly  

Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release

Journal of Medicinal Chemistry, 1974
John M Cassady, James A Clemens, H G Floss   +2 more
exaly  

[Metabolism of ergolinic derivatives].

Bollettino chimico farmaceutico, 1972
F, Arcamone, A H, Glässer, A, Minghetti, V, Nicolella   +3 more
openaire   +1 more source

Synthesis of D-oxa tricyclic partial ergolines as dopamine agonists

Journal of Medicinal Chemistry, 1987
J A Clemens
exaly  

Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines.

Molecular Pharmacology, 1994
M Báez
exaly  

Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.

Journal of Pharmacology and Experimental Therapeutics, 1993
exaly  

Octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine

Journal of Medicinal Chemistry, 1985
exaly